1. Home
  2. IDYA vs BXMT Comparison

IDYA vs BXMT Comparison

Compare IDYA & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$33.40

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Mortgage Trust Inc.

BXMT

Blackstone Mortgage Trust Inc.

HOLD

Current Price

$20.49

Market Cap

3.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
BXMT
Founded
2015
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IDYA
BXMT
Price
$33.40
$20.49
Analyst Decision
Strong Buy
Hold
Analyst Count
14
5
Target Price
$49.42
$20.25
AVG Volume (30 Days)
926.1K
1.2M
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
9.19%
EPS Growth
N/A
N/A
EPS
N/A
0.62
Revenue
$214,834,000.00
$393,335,000.00
Revenue This Year
$2,434.86
N/A
Revenue Next Year
N/A
$10.51
P/E Ratio
N/A
$32.87
Revenue Growth
5377.66
N/A
52 Week Low
$13.45
$16.51
52 Week High
$37.08
$21.24

Technical Indicators

Market Signals
Indicator
IDYA
BXMT
Relative Strength Index (RSI) 49.65 72.89
Support Level $33.12 $19.55
Resistance Level $37.08 $20.67
Average True Range (ATR) 1.47 0.32
MACD -0.36 0.10
Stochastic Oscillator 5.30 90.31

Price Performance

Historical Comparison
IDYA
BXMT

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is a real estate finance company involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.

Share on Social Networks: